Enigmatic Enterococcal Endocarditis
Authors: W. MICHAEL SCHELD
Journal: Annals of Internal Medicine (1984)

Editorials1 June 1984Enigmatic Enterococcal EndocarditisW. MICHAEL SCHELD, M.D., GERALD L. MANDELL, M.D.W. MICHAEL SCHELD, M.D.Search for more papers by this author, GERALD L. MANDELL, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-100-6-904 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptEnterococci are isolated from 10% to 15% of patients with endocarditis (1-3) and rank as the third commonest cause of endocarditis, behind viridans streptococci and Staphylococcus aureus (3). These group D streptococci (Lancefield classification) differ physiologically from most other streptococci by their ability to grow in media containing 40% bile and to cleave esculin. Enterococci are distinguished from nonenterococcal group D organisms (that is, S. bovis or S. equinus) by their growth in broth containing 6.5% sodium chloride. Enterococcal endocarditis is usually caused by S. faecalis and rarely by S. faecium or S. durans.Therapy for patients with enterococcal endocarditis...References1. MANDELL G, KAYE D, LEVISON M, and HOOK E. Enterococcal endocarditis: an analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med. 1970;125:258-64. CrossrefMedlineGoogle Scholar2. LOWES J, HAMER J, and WILLIAMS G. 10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet. 1980;1:133-6. CrossrefMedlineGoogle Scholar3. WILSON W and GERACI J. Antibiotic treatment of infective endocarditis. Annu Re íMed. 1983;34:413-27. CrossrefMedlineGoogle Scholar4. WILKOWSKE C. Enterococcal endocarditis. Mayo Clin Proc. 1982;57:101-5. MedlineGoogle Scholar5. KROGSTAD D and PARQUETTE A. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall. Antimicrob Agents Chemother. 1980;17:965-8. CrossrefMedlineGoogle Scholar6. STORCH G and KROGSTAD D. Antibiotic-induced lysis of enterococci. J Clin Invest. 1981;68:639-45. CrossrefMedlineGoogle Scholar7. SCHELD W and SANDE M. Endocarditis and intravascular infections. In: MANDELL GL, DOUGLAS RG, BENNETT JE, eds. Principles and Practice Infectious Diseases. 2nd ed. New York: John Wiley and Sons; 1984. (In press.) Google Scholar8. DRAKE T and SANDE M. Studies of the chemotherapy of endocarditis: correlation of in vitro, animal model, and clinical studies. Rev. Infect Dis. 1983; 5 (suppl 2):S345-54. CrossrefGoogle Scholar9. SANDE M and SCHELD W. Combination antibiotic therapy of bacterial endocarditis. Ann Intern Med. 1980;92:390-5. LinkGoogle Scholar10. WILSON W, WILKOWSKE C, WRIGHT A, SANDE M, and GERACI J. Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med. 1984;100:816-23. LinkGoogle Scholar11. TOMPSETT R and BERMAN W. Enterococcal endocarditis: duration and mode of treatment. Trans Am Clin Climatol Assoc. 1977;89:49-57. Google Scholar12. PHAIR J and TAN J. Therapy of Streptococcus viridans endocarditis. In: KAPLAN EL, TARANTA AV, eds. Infective Endocarditis: An American Heart Association Symposium. Dallas: American Heart Association; 1977; 55-7. Google Scholar13. MALACOFF R, FRANK E, and ANDRIOLE V. Streptococcal endocarditis (nonenterococcal, non-group A): single vs combination therapy. JAMA. 1979;241:1807-10. CrossrefMedlineGoogle Scholar14. PLANTE D and PAUKER S. Enterococcal endocarditis and penicillin allergy: which drug for the bug? Med Decis Making. 1983;3:81-109. CrossrefMedlineGoogle Scholar15. HERZSTEIN J, RYAN J, MANGI R, GRECO T, and ANDRIOLE V. Optimal therapy for enterococcal endocarditis. Am J Med. 1984;76:186-91. CrossrefMedlineGoogle Scholar16. KOENIG M and KAYE D. Enterococcal endocarditis: report of nineteen cases with longer-term follow-up data. N Engl J Med. 1961;264:257-64. CrossrefMedlineGoogle Scholar17. SERRA P, BRANDIMARTE C, MARTINO P, CARLONE S, and GIUNCHI G. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies. Arch Intern. Med. 1977;137:1562-7. CrossrefMedlineGoogle Scholar18. WEINSTEIN A and MOELLERING R. Penicillin and gentamicin therapy for enterococcal infections. JAMA. 1973;223:1030-2. CrossrefMedlineGoogle Scholar19. WATANAKUNAKORN C and BAKIE C. Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob Agents Chemother. 1973;4:120-4. CrossrefMedlineGoogle Scholar20. FARBER B and MOELLERING R. Retrospective study of the toxicity of preparations of vancomycin for 1974 to 1981. Antimicrob Agents Chemother. 1983;23:138-41. CrossrefMedlineGoogle Scholar21. MEDERSKI-SAMORAJ B and MURRAY B. High level resistance to gentamicin in clinical isolates of enterococci. J Infect Dis. 1983;147:751-7. CrossrefMedlineGoogle Scholar22. MURRAY B and MEDERSKI-SAMAROJ B. Transferable beta-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest. 1983;72:1168-71. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: W. MICHAEL SCHELD, M.D.; GERALD L. MANDELL, M.D.Affiliations: University of Virginia School of Medicine Charlottesville, Viriginia PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byINFECTIVE ENDOCARDITISMicrobiology of Infective Endocarditis and Clinical Correlates: Gram-Positive OrganismsAcute Infective EndocarditisEntérocoques au CHRU de Montpellier durant le mois de septembre 1993 : espèces isolées, répartition en fonction du prélèvement, rôle pathogène, sensibilité aux bêta-lactamines, aminosides, glycopeptidesAntibiotische TherapieEnterococcus faecium resistant to ampicillin and gentamicinEndocarditisThe epidemiology of enterococciThe life and times of the EnterococcusThe enterococci: Evidence of species-specific clinical and microbiologic heterogeneityBinding of fibronectin and albumin to Enterococcus (Streptococcus) faecalisMultiply high-level-aminoglycoside-resistant enterococci isolated from patients in a university hospitalBeta-Lactam AntibioticsContinuous-infusion ampicillin therapy of enterococcal endocarditis in ratsSerodiagnosis of Streptococcus faecalis endocarditis by immunoblotting of surface protein antigens 1 June 1984Volume 100, Issue 6Page: 904-905KeywordsAllergy and immunologyBileEndocarditisInfectious diseasesSodium chlorideStaphylococcus aureus ePublished: 1 December 2008 Issue Published: 1 June 1984 PDF downloadLoading ...